Skip to content

Rafael Holdings, Inc. RFL Purchase Of Preferred Shares And Warrants From Nina Medical

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept rfl:PurchaseOfPreferredSharesAndWarrantsFromNinaMedical.

The official record: Rafael Holdings, Inc.’s 10-Q, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s purchase of preferred shares and warrants from nina medical.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s purchase of preferred shares and warrants from nina medical?
Rafael Holdings, Inc. (RFL) reported purchase of preferred shares and warrants from nina medical of $250K in Q4 2025.